glp-1 for rheumatoid arthritis GLP-1s diabetes reduce arthritis, gout risk GLP-1 Medications and Rheumatoid Arthritis:

This is the first one that just feels like nothing, in the best way

As GLP-1 utilization expanded, new patient volume for hypertension and high cholesterol therapies declined, with 2024 marking the steepest drop, 3% for hypertension and 4% for high cholesterol

Metabolic regulation of NK cell function: implications for immunotherapy

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

The recent development of next-generation sequencing techniques combined with retrospective studies on cancer patients opened new possibilities to better characterize the macrophage subsets in cancer and to further define the pathways involved in their angiogenic signaling